Role of Hydrogen Peroxide and the Impact of Glutathione Peroxidase-1 in Regulation of Cerebral Vascular Tone

Abstract

Although arachidonic acid (AA) has diverse vascular effects, the mechanisms that mediate these effects are incompletely defined. The goal of our study was to use genetic approaches to examine the role of hydrogen peroxide (H₂O₂), glutathione peroxidase (Gpx1, which degrades H₂O₂), and CuZn-superoxide dismutase (SOD1, which produces H₂O₂ from superoxide) in mediating and in determining vascular responses to AA. In basilar arteries in vitro, AA produced dilation in nontransgenic mice, and this response was reduced markedly in transgenic mice overexpressing Gpx1 (Gpx1 Tg) or in those genetically deficient in SOD1. For example, AA (1 nmol/L to 1 μmol/L) dilated the basilar artery and this response was reduced by ∼90% in Gpx1 Tg mice (P<0.01), although responses to acetylcholine were not altered. Dilation of cerebral arterioles in vivo in response to AA was inhibited by ∼50% by treatment with catalase (300 U/mL) (P<0.05) and reduced by as much as 90% in Gpx1 Tg mice compared with that in controls (P<0.05). These results provide the first evidence that Gpx1 has functional effects in the cerebral circulation, and that AA-induced vascular effects are mediated by H₂O₂ produced by SOD1. In contrast, cerebral vascular responses to the endothelium-dependent agonist acetylcholine are not mediated by H₂O₂.

Keywords

acetylcholine basilar artery cerebral arterioles microcirculation reactive oxygen species

Introduction

Arachidonic acid (AA) plays a major role in vascular biology and elicits a variety of effects, including changes in vascular tone and permeability. Such effects may be mediated by multiple mechanisms. Arachidonic acid can potentially alter cell function without being metabolized by acting on specific targets, such as ion channels (Meves, 2008). Moreover, AA can also be metabolized through several major pathways, including cyclooxygenase, cytochrome P450 monooxygenase, and lipoxygenase pathways (Meves, 2008). In addition to producing eicosanoids, the metabolism of AA also results in the generation of reactive oxygen species (ROS) (Kontos, 1990), which have both acute and chronic vascular effects (Faraci, 2006a; Chrissobolis and Faraci, 2008).

In blood vessels from several organs, including the heart and the brain, AA increases ROS levels (Didion et al, 2001a; Oltman et al, 2003; Zafari et al, 1999). Earlier studies using pharmacological approaches have provided evidence both for (Oltman et al, 2003; Sobey et al, 1998) and against (Bryan et al, 2006; Pomposiello et al, 1999) the role for ROS as mediators of changes in vascular tone in response to AA. In this study, we examined the role of ROS, and specifically hydrogen peroxide (H₂O₂), as a mediator of the vascular effects of AA using pharmacological and new genetic approaches. Steady-state levels of H₂O₂ are determined in part by the activity of glutathione peroxidases (Gpx), which metabolizes H₂O₂ to water (Arthur, 2000; Briggelius-Flohe et al, 2003; Faraci, 2006a). The functional importance of Gpx in most vascular beds, including the cerebral circulation is unknown.

The goal of these experiments was to examine the role of H₂O₂ in mediating the effects of AA on vascular tone. We sought to define the functional importance of the cytosolic form of Gpx (Gpx1) as a determinant of this vascular response. We tested the hypothesis that vasodilation to AA is mediated by H₂O₂ and that genetic overexpression of Gpx1 would inhibit this response. As part of these experiments, we also tested whether overexpression of Gpx1 affected dilation of cerebral arteries to the classic endothelium-dependent agonist, acetylcholine.

Superoxide dismutases (SODs) are a major cellular source of H₂O₂ as they convert superoxide to H₂O₂ (Faraci and Didion, 2004). To further define mechanisms involved, we tested the hypothesis that vascular responses to AA depend on the expression of the cytosolic form of SOD (CuZn-SOD or SOD1). In vascular tissue, SOD1 accounts for the majority of total SOD activity (Faraci and Didion, 2004; Didion et al, 2001b). Overall, our findings provide the first evidence that Gpx1 has functional effects in the cerebral circulation and that the vascular effects of AA, but not acetylcholine, are mediated by H₂O₂ produced by SOD1.

Materials and methods

Experimental Animals

Glutathione peroxidase transgenic (Gpx1 Tg) mice (Chrissobolis et al, 2008) were obtained from breeding C57B1/6 and Gpx1 Tg mice. The Gpx1 Tg mice and their nontransgenic littermates (non-Tg) were studied. SOD1-deficient mice were obtained from breeding heterozygous SOD1-deficient mice (Didion et al, 200lb). We studied homozygous SOD1-deficient (SOD1^−/−) mice and their wild-type (SOD1 ^+/+) littermates. Transgenic mice that overexpress renin and angiotensinogen (R⁺A⁺) were obtained as described earlier (Faraci et al, 2006a). Additional C57BL6 mice were used in some studies. All breeding was performed in a virus- and pathogen-free barrier facility at the University of Iowa. Genotyping was performed as described earlier for these strains (Chrissobolis et al, 2008; Didion et al, 2001b, 2002). Mice were fed regular chow and water was available ad libitum. All experimental protocols and procedures conform to the NIH Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of Iowa.

Studies of Cerebral Arteries In Vitro

After an overdose of anesthesia (pentobarbital, 150mg/kg intraperitoneally), the brain was rapidly removed and placed in an ice-cold Krebs buffer. As described earlier (Faraci et al, 2006a, Yamada et al, 2001), the basilar artery was isolated, cannulated onto glass micropipettes filled with Krebs buffer in an organ chamber, and secured using a nylon monofilament. Arteries were pressurized to 60 mm Hg. Using a microscope and a video camera, vessel images were projected on a video monitor. An electronic dimension analyzer was used to measure lumen diameter.

Once prepared, basilar arteries were allowed to equilibrate for at least 30mins at a distending pressure of 60 mm Hg before protocols were initiated. We examined changes in diameter of the basilar artery in response to KCl (50mmol/L). For studies testing vasodilator responses, basilar arteries were constricted by ∼30% (∼60% of the response to 50mmol/L of KCl) with U-46619, a thromboxane A₂ mimetic. Acetylcholine was used as an endothelium-dependent agonist and is known to produce a nitric oxide (NO)-mediated dilation of the basilar artery (Faraci and Heistad, 1998; Faraci et al, 2006b). After development of a stable baseline diameter, cumulative dose-response curves were obtained. At the end of the protocols, papaverine (an endothelium-independent vasodilator, 100 μmol/L) was used to produce maximal vasodilation.

Studies of Cerebral Arterioles In Vivo

Mice were anesthetized with pentobarbital sodium (75 to 90mg/kg intraperitoneally), supplemented regularly at ∼20mg/kg per h. Animals were ventilated mechanically with supplemental oxygen, and the arterial blood pressure and blood gases were monitored as described earlier (Sobey and Faraci, 1997). A cranial window was made over the left parietal cortex; the window constantly suffused with artificial cerebrospinal fluid, and a pial arteriole (branches of the middle cerebral artery) was exposed. The arteriolar diameter was measured using a microscope equipped with a camera coupled to a video monitor and to an image-shearing device. The diameter of one arteriole per animal was measured under control conditions and during topical application of drugs. The mean arterial pressure was similar in all groups of mice and averaged 69 ± 1 mm Hg (mean ± s.e.). Arterial blood gases were monitored and were also similar (PCO₂ = 41 ± 1 mm Hg, PO₂ = 128 ± 10 mm Hg, and pH = 7.28 ± 0.01). The gases and pH of the artificial cerebrospinal fluid were PCO₂ = 40 ± 1 mm Hg, PO₂ = 73 ± 2 mm Hg, and pH = 7.32 ± 0.02. In these studies, responses of arterioles to topical application of AA (1 and 10 μmol/L), acetylcholine (1 and 10 μmol/L), and papaverine (10 and 100 μmol/L) were examined in the absence or presence of catalase (300 U/mL, a scavenger of H₂O₂) or diethyldithiocarbamate (10 mmol/L, an inhibitor of SOD1 and SOD3) (Faraci and Didion, 2004). These latter experiments were carried out to examine whether responses to AA and the mechanisms involved in the mouse were similar to earlier studies in other species (Didion et al, 2001a; Sobey et al, 1998).

Statistical Analysis

For the basilar artery, constriction in response to KCl was determined by calculating the percentage reduction in vessel diameter from the baseline control level. For vasodilator responses, results are expressed as percentage dilation (% of induced tone), with 100% representing the difference between the resting value under basal conditions and the constricted value with U-46619. For cerebral arterioles in vivo, results are expressed as percentage dilation (% change). As appropriate, comparisons were made using paired or unpaired t-tests or ANOVA (analysis of variance) with repeated measures followed by the Student-Newman-Keuls test to detect individual differences. A value P < 0.05 was defined as significant.

Results

Dilation of Cerebral Arterioles to Arachidonic Acid is Inhibited by Catalase

The baseline diameter of cerebral arterioles in all C57Bl6/J mice in vivo was 32 ± 1 μm. Catalase had no significant effect on the baseline diameter (33 ± 1 versus 34 ± 1 μm). Dilation of cerebral arterioles in response to AA (n = 9), but not to papaverine, was inhibited by catalase (Figure 1). These data provide pharmacological evidence that AA-induced vasodilation is mediated by H₂O₂. In time-control experiments in a separate group of mice (n = 5), responses of cerebral arterioles to AA were reproducible in the absence of any inhibitor (data not shown).

Figure 1

Changes in the diameter of cerebral arterioles in response to arachidonic acid (left panel) and papaverine (right panel) in C57BI/6 mice in the absence (control) and presence of catalase (300 U/mL). Values are means ± s.e.; *P < 0.05 versus control.

Vasodilation to Arachidonic Acid is Inhibited by Indomethacin

The baseline diameter of the basilar artery in C57Bl6/J mice was 128 ± 10 μm. Dilation of the basilar artery in response to AA was completely inhibited by indomethacin (10 μmol/L, n = 4) (Figure 2). We have shown earlier that indomethacin does not alter dilation of the mouse basilar to 14,15-epoxyeicosatrienoic acid (Fang et al, 2006).

Figure 2

Changes in the diameter of the basilar artery in response to arachidonic acid in the absence and presence of indomethacin (10 μmol/L, n = 4). The baseline diameter of the basilar artery was 128 ± 10 μm under control conditions and 91 ± 7 μm after preconstriction with U46619. Values are means ± s.e.; *P < 0.001 versus control.

Overexpression of Glutathione Peroxidase Markedly Reduces Dilation of the Basilar Artery and Cerebral Arterioles to Arachidonic Acid

We have shown earlier that vascular expression of Gpx1 is increased approximately three-fold in Gpx1 Tg mice compared with that in non-Tg controls (Chrissobolis et al, 2008). Baseline diameters of the basilar artery in non-Tg and Gpx1 Tg mice were 132 ± 1 and 130 ± 2 μm (n = 10 for each genotype), respectively. Dilator responses of the basilar artery to AA were reduced by ∼90% in Gpx1 Tg mice (Figure 3). For example, 1 μmol/L of AA dilated the basilar artery by 53 ± 2% and 7 ± 1% in control and in Gpx1 Tg mice, respectively. Hydrogen peroxide is known to dilate cerebral arterioles (Faraci, 2006b; Sobey et al, 1997). Exogenous H₂O₂ produced dilation of the basilar artery, and this response was inhibited by ∼50% in Gpx1 Tg mice (Figure 3). These inhibitory effects were selective, as the basilar artery constricted similarly to KCl (Figure 3) and U46619 (data not shown) and dilated similarly to acetylcholine and papaverine in both groups of mice (Figure 3).

Figure 3

Changes in the diameter of the basilar artery in response to arachidonic acid (upper left panel) and acetylcholine (lower left panel) in non-Tg (nontransgenic) and glutathione peroxidase Tg (Gpx1 Tg) mice. Effects of hydrogen peroxide on vessel diameter in non-Tg mice (upper middle panel) and in non-Tg and Gpx1 Tg mice (upper right panel). Vascular responses to papaverine and KCI are also shown (lower middle panel and lower right panel, respectively). In non-Tg and Gpx1 Tg mice, respectively, the vessel diameters were 131 ± 4 and 130 ± 5 μm under baseline conditions and 92 ± 4 and 91 ± 4 μm after preconstriction with U46619. Values are means ± s.e.; *P < 0.05 versus non-Tg mice unless otherwise noted.

In vivo, the baseline diameter was similar in cerebral arterioles from control and Gpx1 Tg mice (28 ± 1 and 27 ± 1 μm in non-Tg (n = 9) and Gpx1 Tg mice (n = 9), respectively). Dilation of cerebral arterioles in response to AA, but not to papaverine, was markedly reduced in Gpx1 Tg mice compared with that in controls (Figure 4).

Figure 4

Changes in the diameter of cerebral arterioles in response to arachidonic acid (left panel) and papaverine (right panel) in nontransgenic controls (non-Tg) and glutathione peroxidase (Gpx1) Tg mice. Values are means ± s.e.; *P < 0.05 versus non-Tg mice.

Vasodilation to Arachidonic Acid is Greatly Attenuated in SOD1-Deficient Mice

Baseline diameters of the basilar artery in wild-type and SOD1-deficient mice were 135 ± 2 and 133 ± 2 μm (n = 8 and n = 9), respectively. Maximal dilator responses of the basilar artery to AA were reduced by ∼ 75% in SOD1-deficient mice (Figure 5). For example, 1 μmol/L of arachidonate dilated the basilar artery by 70 ± 3% and 18 ± 1% in wild-type and SOD1-deficient mice, respectively (Figure 5).

Figure 5

Changes in the diameter of the basilar artery in response to arachidonic acid (upper left) and acetylcholine (upper right) in wild-type and in SOD1-deficient mice. The effect of DDC on changes in the diameter of cerebral arterioles in response to acetylcholine in C57BI/6 mice are also shown (upper middle panel). Vascular responses to papaverine and KCl are also shown (lower left and lower middle, respectively). KO = knockout. Effects of arachidonic acid on basilar artery diameter in a control R⁺ A⁺ mice are shown in the lower right panel. In wild-type and SOD1-deficient mice respectively, vessel diameters were 136 ± 6 and 136 ± 6 μm under baseline conditions and 97 ± 5 and 102 ± 5 μm after preconstriction with U46619. In control and R⁺ A⁺ mice respectively, vessel diameters were 141 ± 4 and 140 ± 3 μm under baseline conditions and 99 ± 3 and 95 ± l μm after preconstriction with U46619. Values are means ± s.e.; *P < 0.05 versus control or wild-type mice unless otherwise noted.

We and others have shown that genetic deficiency in SOD1 reduces formation of H₂O₂, increases superoxide, and impairs NO-mediated vascular responses (Didion et al, 2001b; Baumbach et al, 2006; Yada et al, 2008). Consistent with earlier studies in cerebral arterioles (Didion et al, 2001a), diethyldithiocarbamate inhibited dilation of cerebral arterioles in response to acetylcholine (Figure 5). Dilation of the basilar artery in response to acetylcholine was reduced in SOD1-deficient mice (Figure 5). This change was selective as constriction of the basilar artery to KCl (Figure 5) and U46619 (data not shown), and dilation to papaverine was similar in both groups of mice (Figure 5).

As deficiency in SOD1 produces oxidative stress, we considered the possibility that reductions in the response to AA in SOD1-deficient mice were simply a consequence of oxidative stress. To examine this possibility, we studied basilar arteries from a genetic model of angiotensin II-dependent hypertension (R⁺A⁺ mice) (Didion et al, 2002). R⁺A⁺ mice have oxidative stress, increased vascular superoxide, and superoxide-mediated vascular dysfunction (Didion et al, 2002; Faraci et al, 2006a). Vasodilation in response to AA was not altered in R⁺A⁺ mice compared with that in littermate controls (Figure 5), suggesting that the presence of oxidative stress per se does not impair responses to AA.

Discussion

There are several novel findings in this study. Arachidonic acid dilated cerebral blood vessels both in vivo and in vitro. The in vitro data show that effects of AA reflect direct actions on the vessel wall and depend on the activity of cyclooxygenase. Overexpression of Gpx1 markedly reduced responses to AA, providing genetic evidence that H₂O₂ mediates the majority of the effect on vascular tone. Our findings with exogenous application of catalase support this concept. Using Gpx1 Tg mice, similar findings were obtained in a cerebral artery studied in vitro and in small microvessels with myogenic tone studied in vivo. To our knowledge, this is first evidence of any kind that Gpx1 is functionally important in the cerebral circulation. We also found that genetic deficiency in SOD1 markedly reduced responses to AA, suggesting that the majority of the vascular response is mediated by H₂O₂ produced by this form of SOD. Our study provides new genetic evidence regarding the role of H₂O₂ and mechanisms that mediate the vascular effects of AA. Finally, our data suggest strongly that responses of cerebral blood vessels to the endothelium-dependent agonist, acetylcholine, are not mediated by H₂O₂.

Cerebrovascular Effects of Arachidonic Acid and the Role of Reactive Oxygen Species

Arachidonic acid is generally a vasodilator, including in the cerebral circulation. Although AA has the potential to produce vascular effects through direct actions on ion channels and following metabolism through multiple pathways, most earlier studies in multiple species, including primates indicate that AA produces changes in the tone of cerebral arteries and arterioles through a cyclooxygenase-dependent mechanism (Busija and Heistad, 1983; Ellis et al, 1990; Hayashi et al, 1985; Niwa et al, 2001; Sobey et al, 1998). In this study, we found that indomethacin completely inhibited the vascular effects of AA, indicating that the response was also dependent on the activity of cyclooxygenase in the mouse basilar artery. As the vascular effects of AA are reduced by cyclooxygenase inhibitors, some investigators assume that prostacyclin or other eicosanoids mediates these responses (Hayashi et al, 1985; Ospina et al, 2003).

The metabolism of AA is known to be a major source of ROS (Kontos, 1990). Superoxide is produced during cyclooxygenase activity (i.e., the conversion of AA to prostaglandin H₂) (Kontos, 1990). For example, AA produces cyclooxygenase-dependent superoxide formation in cerebral and coronary blood vessels (Didion et al, 2001a; Oltman et al, 2003). Once produced, superoxide may have direct effects (Faraci, 2006b; Faraci and Didion, 2004) or may be converted to H₂O₂ primarily by SODs (Faraci and Didion, 2004; Faraci, 2006a). Although some earlier studies suggest that vasodilation in response to AA is inhibited by scavengers of ROS, there is controversy regarding the role of ROS and which ROS mediate the response (Bryan et al, 2006; Kontos et al, 1984; Niwa et al, 2001; Pomposiello et al, 1999; Sobey et al, 1998). Our finding that dilation of cerebral arterioles in response to AA is inhibited by catalase supports the concept that ROS are key components and that H₂O₂ is a mediator of this response (Kontos et al, 1984; Sobey et al, 1998).

In the cerebral circulation and other vascular beds, H₂O₂ is generally a dilator in both large arteries and microvessels (see Faraci, 2006a, b for reviews). A similar effect was observed in this study, as H₂O₂ was a potent dilator of the basilar artery. Although there is little evidence to suggest that ROS affect cerebral vascular tone under resting conditions, some pharmacological studies suggested that dilation of cerebral arterioles to both AA and bradykinin is mediated by an endogenous formation of ROS. We provided the first evidence that H₂O₂ dilates cerebral arterioles by activation of potassium channels (Sobey et al, 1997, 1998) and thus, may function as an endothelium-derived hyperpolarizing factor. In addition to these stimuli, H₂O₂ may contribute to flow-mediated vasodilation (Paravicini et al, 2006) and increases in cerebral blood flow in diseases with an inflammatory component, including meningitis (Hoffmann et al, 2007).

Is SOD1 a Major Source of Hydrogen Peroxide in the Cerebral Circulation?

As noted above, H₂O₂ is formed primarily from superoxide as a result of activity of the various SODs (Faraci and Didion, 2004). In blood vessels, there are three isoforms of SOD, namely SOD1, manganese SOD localized in mitochondria (SOD2), and an extracellular form of CuZn-SOD (SOD3) (Faraci and Didion, 2004). Vasodilation of cerebral arterioles in response to AA was markedly reduced by diethyldithiocarbamate (Didion et al, 2001a), an inhibitor of SOD1 and SOD3 (Faraci and Didion, 2004), suggesting the source of H₂O₂ that mediates the response is a copper-containing SOD. However, this approach is limited and provides no insight into the relative importance of the specific isoforms of SOD. In addition, diethyldithiocarbamate is a chelator of copper and thus, may have nonselective effects (Faraci and Didion, 2004). In these experiments, we found that vasodilation to AA was markedly reduced in mice deficient in SOD1, suggesting this response is mediated very predominately by H₂O₂ produced by SOD1.

We and others have shown that pharmacological inhibition of SOD1 and SOD3 or genetic deficiency in SOD1 increase vascular superoxide (Baumbach et al, 2006; Didion et al, 2001a, b ), reduce vascular H₂O₂, (Yada et al, 2008), and impair NO-mediated vascular responses (Baumbach et al, 2006; Didion et al, 2001a, b ). Consistent with this concept, we found that dilation of cerebral arterioles to acetylcholine was inhibited by diethyldithiocarbamate and that responses of the basilar artery to acetylcholine were impaired in SOD1-deficient mice. In both these vascular segments, multiple lines of evidence suggest that vasodilation to acetylcholine is normally mediated by endothelium-derived NO (Faraci and Heistad, 1998; Sobey and Faraci, 1997).

Glutathione Peroxidase is a Major Determinant of Vascular Responses to Arachidonic Acid

Glutathione peroxidases are part of a family of selenium-dependent enzymes that use glutathione to metabolize H₂O₂ and lipid peroxides to water and respective alcohols (Arthur, 2000; Briggelius-Flohe et al, 2003). Similar to the SODs, there are multiple isoforms of Gpx, including the cytosolic Gpx1 (Arthur, 2000; Briggelius-Flohe et al, 2003). Gpx is expressed in vascular cells and blood vessels, including cerebral arteries (Chrissobolis et al, 2008; Kobayashi et al, 2002; Lapenna et al, 1998; Napoli et al, 1999). The expression of Gpx is relatively high in endothelium (Kobayashi et al, 2002), and may change within the vessel wall depending on genetic factors and in disease (Lapenna et al, 1998; Ulker et al, 2003). Although catalase also degrades H₂O₂, human vascular cells reportedly express little or no catalase (Shingu et al, 1985).

Although exogenous catalase had inhibitory effects on vascular responses to AA, that approach may underestimate the role of intracellularly produced H₂O₂ and provides no insight into the subcellular action of H₂O₂ or into the functional importance of GPx1. The existence of multiple isoforms of SOD and GPx implies that specific functions exist in different subcellular locations. Increasing evidence suggests that the effects of ROS are compartmentalized with different signaling consequences at different locations. Our findings with Gpx1 Tg mice provide genetic evidence that H₂O₂ is the mediator of the majority of the vascular response to AA, particularly with lower concentrations of arachidonate. We earlier provided evidence that Gpx1 has functional effects in the carotid artery and was important in protecting against angiotensin II-induced vascular dysfunction (Chrissobolis et al, 2008). The present study provides the first evidence that Gpx1 has functional effects in the cerebral circulation (in intracranial blood vessels). It is perhaps not surprising that the response to AA is dependent on the activities of both SOD1 and Gpx1 as both these enzymes are cytosolic as opposed to other forms of SOD and Gpx.

Role of Hydrogen Peroxide in Mediating Endothelium-Dependent Relaxation

Many studies suggest that NO produced by eNOS (endothelial isoform of NO synthase) affects basal tone and mediates responses to varied endothelium-dependent stimuli (Faraci and Heistad, 1998; Cipolla and Bullinger, 2008; Cipolla et al, 2004), In contrast, a recent study suggests that under normal conditions, eNOS is uncoupled in cerebral arteries and thus, produces superoxide because of a deficiency in substrate (Drouin et al, 2007). In this scenario, the superoxide is produced by eNOS and is then converted to H₂O₂ by SOD(s). With this postulated mechanism, H₂O₂ is the actual mediator of endothelium-dependent relaxation (Drouin et al, 2007). Our finding that overexpression of Gpx1 greatly reduces vascular responses to AA and exogenous H₂O₂, but not acetylcholine, do not support the concept that H₂O₂ is the mediator of responses to this neurotransmitter and muscarinic agonist. These findings are consistent with earlier pharmacologically based studies that concluded that responses to acetylcholine in the cerebral circulation are not mediated by ROS (see Katusic et al, 1989; Kontos et al, 1988 for examples). Uncoupled eNOS may well contribute to oxidative stress in vascular disease, including the brain, but there has been little evidence to suggest that this form of dysfunction occurs under normal conditions in vivo (Chrissobolis and Faraci, 2008).

In summary, this study provides the first genetic evidence that the vascular effects of AA are mediated by H₂O₂ produced by SOD1. Our study suggests that Gpx1 is a major determinant of the vascular effects of AA both in vitro and in vivo. Effects of lower concentrations of AA (1 μmol/L and less) were almost completely inhibited after overexpression of Gpx1 in both the basilar artery and cerebral arterioles. These findings support the concept that blood vessels can use ROS as key signaling molecules under normal conditions. The concentrations of AA used in these experiments are well within the physiologic range (Meves, 2008). Higher local concentrations of AA may occur with disease or cellular injury and may affect blood vessels by additional mechanisms, including activation of two-pore-domain potassium channels (Bryan et al, 2006).

References

Arthur

(2000) The glutathione peroxidases. Cell Mol Life Sci 57:1825–35

Baumbach

Didion

Faraci

(2006) Hypertrophy of cerebral arterioles in mice deficient in expression of the gene for CuZn superoxide dismutase. Stroke 37:1850–5

Briggelius-Flohe

Banning

Schnurr

(2003) Selenium-dependent enzymes in endothelial cell function. Antioxid Redox Signal 5:205–15

Bryan

You

Phillips

Andresen

Lloyd

Rogers

Dryer

Marrelli

(2006) Evidence for two-pore domain potassium channels in rat cerebral arteries. Am J Physiol 291:H770–80

Busija

Heistad

(1983) Effects of indomethacin on cerebral blood flow during hypercapnia in cats. Am J Physiol 244:H519–24

Cipolla

Bullinger

(2008) Reactivity of brain parenchymal arterioles after ischemia and reperfusion. Microcirculation 15:495–501

Cipolla

Vitullo

McKinnon

(2004) Cerebral artery reactivity changes during pregnancy and the postpartum period: A role in eclampsia. Am J Physiol 286:H2127–32

Chrissobolis

Didion

Kinzenbaw

Schrader

Dayal

Lentz

Faraci

(2008) Glutathione peroxidase plays a major role in protecting against angiotensin II-induced vascular dysfunction. Hypertension 51:872–7

Chrissobolis

Faraci

(2008) The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med 14:495–502

10.

Didion

Hathaway

Faraci

(2001a) Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD. Am J Physiol 281:H1697–703

11.

Didion

Ryan

Baumbach

Sigmund

Faraci

(2002) Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen. Am J Physiol 283:H1569–76

12.

Didion

Ryan

Didion

Fegan

Sigmund

Faraci

(2001b) Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res 91:938–44

13.

Drouin

Thorin-Trescases

Hamel

Falck

Thorin

(2007) Endothelial nitric oxide synthase activation leads to dilatory H₂O₂ production in mouse cerebral arteries. Cardiovasc Res 73:73–81

14.

Ellis

Police

Yancey

McKinney

Amruthesh

(1990) Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol 259:H1171–7

15.

Fang

Faraci

Kaduce

Harmon

Modrick

Moore

Falck

Weintraub

Spector

(2006) 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: Role of cyclooxygenase. Am J Physiol 291:H2301–7

16.

Faraci

(2006a) Hydrogen peroxide: Watery fuel for change in vascular biology. Arterioscler Thromb Vasc Biol 26:1931–3

17.

Faraci

(2006b) Reactive oxygen species: Influence on cerebral vascular tone. J Appl Physiol 100:739–43

18.

Faraci

Didion

(2004) Vascular protection: Superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24:1367–73

19.

Faraci

Heistad

(1998) Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiol Rev 78:53–97

20.

Faraci

Lamping

Modrick

Ryan

Sigmund

Didion

(2006a) Cerebral vascular effects of angiotensin II: New insights from genetic models. J Cereb Blood Flow Metab 26:449–55

21.

Faraci

Modrick

Lynch

Didion

Fegan

Didion

(2006b) Selective cerebral vascular dysfunction in Mn-SOD-deficient mice. J Appl Physiol 100:2089–93

22.

Hayashi

Park

Kuehl

(1985) Relaxant and contractile responses to prostaglandins in premature, newborn and adult baboon cerebral arteries. J Pharmacol Exp Ther 233:628–35

23.

Hoffmann

Becker

Weber

(2007) Bacterial hydrogen peroxide contributes to cerebral hyperemia during early stages of experimental pneumococcal meningitis. J Cereb Blood Flow Metab 27:1792–7

24.

Katusic

Marshall

Kontos

Vanhoutte

(1989) Similar responsiveness of smooth muscle of the canine basilar artery to EDRF and nitric oxide. Am J Physiol 257:H1235–9

25.

Kobayashi

Inoue

Azumi

Seno

Hirata

Kawashima

Hayashi

Itoh

Yokosaki

Yokoyama

(2002) Expressional changes of the vascular oxidant system in atherosclerotic coronary arteries. J Atheroscler Thromb 9:184–90

26.

Kontos

(1990) Role of products of univalent reduction of oxygen in hypertensive vascular injury. In: Hypertension: pathophysiology, diagnosis, and management ( Laragh

Brenner

, eds), NY: Raven Press Chapter 44) 667–75

27.

Kontos

Wei

Marshall

(1988) In vivo bioassay of endothelium-derived relaxing factor. Am J Physiol 255:H1259–62

28.

Kontos

Wei

Povlishock

Christman

(1984) Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats. Circ Res 55:295–303

29.

Lapenna

de Gioia

Ciofani

Mezzetti

Ucchino

Calafiore

Napolitano

Di Ilio

Cuccurullo

(1998) Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 97:1930–4

30.

Meves

(2008) Arachidonic acid and ion channels: An update. Br J Pharmacol 155:4–16

31.

Napoli

Witztum

de Nigris

Palumbo

D'Armiento

Palinski

(1999) Intracranial arteries of human fetuses are more resistant to hypercholesterolemiainduced fatty streak formation than extracranial arteries. Circulation 99:2003–10

32.

Niwa

Haensel

Ross

Iadecola

(2001) Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ Res 88:600–8

33.

Ospina

Duckies

Krause

(2003) 17ß-estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation. Am J Physiol 285:H241–50

34.

Oltman

Kane

Miller

Spector

Weintraub

Dellsperger

(2003) Reactive oxygen species mediate arachidonic acid-induced dilation in porcine coronary microvessels. Am J Physiol 285: H2309–15

35.

Paravicini

Miller

Drummond

Sobey

(2006) Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH-oxidase, and nitric oxide synthase. J Cereb Blood Flow Metab 26:836–45

36.

Pomposiello

Rhaleb

Alva

Carretero

(1999) Reactive oxygen species: Role in the relaxation induced by bradykinin or arachidonic acid via EDHF in isolated porcine coronary arteries. J Cardiovasc Pharmacol 34:567–74

37.

Shingu

Yoshioka

Nobunaga

Yoshida

(1985) Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide. Inflammation 9:309–20

38.

Sobey

Faraci

(1997) Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Stroke 28:837–42

39.

Sobey

Heistad

Faraci

(1997) Mechanisms of bradykinin-induced cerebral vasodilatation: Evidence that reactive oxygen species activate K⁺ channels. Stroke 28:2290–5

40.

Sobey

Heistad

Faraci

(1998) Potassium channels mediate dilatation of cerebral arterioles in response to arachidonate. Am J Physiol 275:H1606–12

41.

Ulker

McMaster

McKeown

Bayraktutan

(2003) Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc Res 59:488–500

42.

Yada

Shimokawa

Morikawa

Takaki

Shinozaki

Mori

Goto

Ogasawara

Kajiya

(2008) Role of Cu, Zn-SOD in the synthesis of endogenous vasodilator hydrogen peroxide during reactive hyperemia in mouse mesenteric microcirculation in vivo. Am J Physiol 294:H441–8

43.

Yamada

Lamping

Duttaroy

Zhang

Cui

Bymaster

McKinzie

Felder

Deng

C-X

Faraci

Wess

(2001) Cholinergic dilation of cerebral blood vessels is abolished in M₅ muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 98:14096–101

44.

Zafari

Ushio-Fukai

Minieri

Akers

Lassègue

Griendling

(1999) Arachidonic acid metabolites mediate angiotensin Il-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells. Antioxid Redox Signal 1:167–79